These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15701297)

  • 1. Children with hepatitis C.
    Rao GS; Molleston JP
    Curr Gastroenterol Rep; 2005 Feb; 7(1):37-44. PubMed ID: 15701297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hepatitis C virus infection in childhood.
    Galoppo M; Galoppo C
    Ann Hepatol; 2010; 9 Suppl():98-102. PubMed ID: 20714004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Hepatitis C Infection in Children.
    Pham YH; Rosenthal P
    Adv Pediatr; 2016 Aug; 63(1):173-94. PubMed ID: 27426900
    [No Abstract]   [Full Text] [Related]  

  • 4. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
    Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
    Michielsen P; Ho E; Francque S
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and C in children.
    Hsu EK; Murray KF
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jun; 5(6):311-20. PubMed ID: 18414457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of pegylated interferon-α plus ribavirin-based therapy in antiviral treatment of chronic hepatitis C in China].
    Zhu F; Zhang QY; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):173-174. PubMed ID: 29807402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C.
    Majda-Stanisławska E; Bednarek M; Jóźwiak B; Sidorkiewicz M; Piekarska A; Kuydowicz J
    Acta Gastroenterol Belg; 2006; 69(2):187-90. PubMed ID: 16929613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of chronic hepatitis C].
    Schaffstein S; Rampini SK; Müllhaupt B
    Praxis (Bern 1994); 2014 Apr; 103(8):423-36. PubMed ID: 24713377
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic hepatitis C].
    Fehér J; Lengyel G
    Orv Hetil; 2004 May; 145(20):1065-7. PubMed ID: 15202329
    [No Abstract]   [Full Text] [Related]  

  • 11. Management strategies for hepatitis C virus infection in children.
    Davison SM; Kelly DA
    Paediatr Drugs; 2008; 10(6):357-65. PubMed ID: 18998746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy.
    Lackner H; Moser A; Deutsch J; Kessler HH; Benesch M; Kerbl R; Schwinger W; Dornbusch HJ; Preisegger KH; Urban C
    Pediatrics; 2000 Oct; 106(4):E53. PubMed ID: 11015548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C in Egypt, a iatrogenic epidemic].
    Vrolijk JM; Schalm SW
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2378. PubMed ID: 11129975
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of hepatocellular carcinoma (HCC) in peginterferon and ribavirin HCV-infected cirrhotic treated patients.
    Iborra Colomino M; Aguilera Sancho-Tell V; Berenguer Haym M
    Rev Esp Enferm Dig; 2006 Oct; 98(10):794-5. PubMed ID: 17094732
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C with normal liver enzymes: to treat or not to treat. Pro: most patients should be treated.
    Koff JM; Younossi Z
    Am J Gastroenterol; 2004 Jun; 99(6):972-3. PubMed ID: 15180709
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C virus infection in children.
    Chang MH
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Apr; 14(2):341-50. PubMed ID: 10890326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin.
    Todorovska B; Joksimovic N; Caloska-Ivanova V; Dimitrova-Genadieva M; Trajkovska M; Curakova E; Kiprijanovska S; Zafirova-Ivanovska B; Serafimoski V
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar; 38(1):25-33. PubMed ID: 28593897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From trials to a real hospital setting: effectiveness of pegylated interferon-alpha-2b/ribavirin combination therapy for naïve chronic hepatitis C patients.
    Piai G; Scalice E; Focareta R; Terracciano F; de Filippo FR; Forte G
    Dig Dis Sci; 2006 Sep; 51(9):1619-26. PubMed ID: 16927136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.